Effectiveness of the antiseptic barrier cap on rate of bloodstream infections
- Conditions
- sepsis, central line associated bloodstream infection, infants, children, intensive care
- Registration Number
- NL-OMON26906
- Lead Sponsor
- Erasmus MC-Sophia, Department of Paediatrics, Division of Neonatology
- Brief Summary
planned
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1700
Inclusion Criteria
All infants admitted to the Neonatal Intensive Care Unit with peripheral catheter, tunneled and non-tunneled central venous catheters, and/or umbilical catheters.
Pediatric Intensive Care Unit all children with a tunneled and non-tunneled central venous catheters, and/or umbilical catheters and combined with a periferal catheter.
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of CLABSI per 1.000 central line days
- Secondary Outcome Measures
Name Time Method - Compliance of the Healthcare workers who use the antiseptic barrier cap. <br /><br>- Incidence of bloodstream infections<br /><br>- Costs